Intravitreal injections: Guidelines to minimize the risk of endophthalmitis

Retinal Vascular Disease

Volumn , Issue , 2007, Pages 283-288

  Scott, Ingrid U ^a   Flynn Jr , Harry W ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955066785     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-29542-6_18     Document Type: Chapter

References (44)

1. Aiello LP, Brucker AJ, Chang S, et al. (2004) Evolving guidelines for intravitreous injections. Retina 24:S3-S19
2. Antcliff RJ, Spalton DJ, Stanford MR, et al. (2001) Intravi-treal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108: 765-772
3. Bannerman TL, Rhoden DL, McAllister SK, et al. (1997) The source of coagulase-negative staphylococci in the Endoph-thalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol 115:357-361
4. Bucci FA, Amico LM, Guerino A, Evans R (2003) The effect of preop lid scrubs and levofloxacin on eyelid and conjunctival cultures prior to cataract surgery. Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL
5. Cekic O, Change S, Tseng JJ, et al. (2005) Intravitreal triam-cinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 25:851-855
6. Chang TS, Tonnu IQ, Globe DR, Fine J (2004) Longitudinal changes in self-reported visual functioning in AMD patients in a randomized controlled phase I/II trial of Lucentis (rani-bizumab; rHuFAV v2). Invest Ophthal Vis Sci 45:E-Abstract 3098
7. Cibis PA, Becker B, Okun E, Canaan S (1962) The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol 68:590-599
8. Forster RK, Zachary IG, Cottingham AJ Jr, Norton EWD (1976) Further observations on the diagnosis, cause, and treatment of endophthalmitis. Am J Ophthalm 81:52-56
9. Gragoudas ES, et al., for the VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805-2816
10. Greenberg PB, Martidis A, Rogers AH, et al. (2002) Intravi-treal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86:247-248
11. Grimes S, Mein C, Trevino S (1991) Preoperative antibiotic and povidone-iodine preparation of the eye. Ann Ophthal-mol 23:263-266
12. Han DP, Wisniewski SR, Wilson LA, et al. (1996) Spectrum and susceptibilities of microbiologic isolates in the Endoph-thalmitis Vitrectomy Study. Am J Ophthalmol 122:1-17
13. Henry K, Cantrill H, Fletcher C, et al. (1987) Use of intravi-treal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol 103:17-23
14. Hovding G, Sjursen H (1982) Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles. Acta Ophthalmol (Copenh) 60:213-222
15. Isenberg S, Apt L, Yoshimori R, Khwarg S (1985) Chemical preparation of the eye in ophthalmic surgery IV: comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 103:1340-1342
16. Jager RD, Aiello LP, Patel SC, et al. (2004) Risks of intravitreo-us injection: a comprehensive review. Retina 24:676-698
17. Jonas JB, Akkoyun I, Kamppeter B, et al. (2005) Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 19:65-71
18. Jonas JB, Kreissig I, Degenring RF (2003) Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 121:1663-1664
19. Kozak I, Cheng L, Freeman WR (2005) Lidocaine gel anesthesia for intravitreal drug administration. Retina 25:994-998
20. Leong JK, Shah R, McCluskey PJ, et al. (2002) Bacterial contamination of the anterior chamber during phacoemulsifi-cation cataract surgery. J Cataract Refract Surg 28:826-833
21. Martidis A, Duker JS, Greenberg PB, et al. (2002) Intravitre-al triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920-927
22. Martidis A, Duker JS, Puliafito CA (2001) Intravitreal tri-amcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 119:1380-1383
23. Miller JJ, Scott IU, Flynn HW Jr, et al. (2005) Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 139:983-987
24. Moshfeghi AA, Scott IU, Flynn HW Jr, Puliafito CA (2004) Pseudohypopyon after intravitreal triamcinolone acetoni-de injection for cystoid macular edema. Am J Ophthalmol 138:489-492
25. Moshfeghi DM, Kaiser PK, Bakri SJ, Kaiser RS, Maturi RK, Sears JE, Scott IU, Belmont J, Beer PM, Quiroz-Mercado H, Mieler WF (2005) Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging 36:24-29
26. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF (2003) Acute endophthalmitis following intravitreal triamcino-lone acetonide injection. Am J Ophthalmol 136:791-796
27. Nelson ML, Tennant MT, Sivalingam A, et al. (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23: 686-691
28. Ohm J (1911) Über die Behandlung der Netzhautablösung durch operative Entleerung der Subretinalen Flössigkeit und Einspritzung von Luft in den Glaskörper. Albrecht von Graefes Arch Ophthalmol 79:442-450
29. Osher RH, Amdahl LD, Cheetham JK (1994) Antimicrobial efficacy and aqueous humor concentration of preoperative and postoperative topical trimethoprim/polymyxin B sulfate versus tobramycin. J Cataract Refract Surg 20:3-8
30. Ozkiris A, Evereklioglu C, Erkilic K, Ilhan O (2005) The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol 15:96-101
31. Peyman GA, Vastine DW, Raichand M (1978) Experimental aspects and their clinical application. Ophthalmology 85:374-385
32. Rosengren B (1952) 300 cases operated upon for retinal detachment; method and results. Acta Ophthalmol (Copenh) 30:117-122
33. Roth DB, Chieh J, Spirn MJ, et al. (2003) Non-infectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121:1279-1282
34. Rycroft B (1945) Penicillin and the control of deep intraocular infection. Br J Ophthalmol 29:57-87
35. Schneider J, Frankel SS (1947) Treatment of late postoperative intraocular infections with intraocular injection of penicillin. Arch Ophthalmol 37:304-307
36. Scott IU, Ip MS (2005) It's time for a clinical trial to investigate intravitreal triamcinolone for macular edema associated with retinal vein occlusion: the SCORE study. Arch Ophthalmol 123:581-582
37. Speaker MG, Menikoff JA (1991) Prophylaxis of endoph-thalmitis with topical povidone-iodine. Ophthalmology 98:1769-1775
38. Speaker MG, Milch FA, Shah MK, et al. (1991) Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98:639-649; discussion 650
39. Sutter FK, Gillies MC (2003) Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 87:972-974
40. Ta CN, Egbert PR, Singh K, et al. (2002) Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology 109:2036-2041
41. The Eyetech Study Group (2002) Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macu-lar degeneration. Retina 22:143-152
42. The Eyetech Study Group (2003) Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascula-rization secondary to age-related macular degeneration: phase II study results. Ophthalmology 110:979-986
43. Vitravene injection (fomivirsen sodium intravitreal injectable). Approval letter, pages 1-4. Vol 2004. U.S. Food and Drug Adminstration website. Available at: www.fda.gov/cder/foi/nda/98/20961-Vitravene-Approv.pdf. Accessed April 29, 2004
44. Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macu-lar oedema in uveitis. Clin Exp Ophthalmol 29:2-6